Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable-Instituto de Salud Carlos III (CIBERFES-ISCIII), INCLIVA, 46010 Valencia, Spain.
Cardiology Department, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
Int J Mol Sci. 2022 Nov 23;23(23):14632. doi: 10.3390/ijms232314632.
Aging is associated with an alteration of intercellular communication. These changes in the extracellular environment contribute to the aging phenotype and have been linked to different aging-related diseases. Extracellular vesicles (EVs) are factors that mediate the transmission of signaling molecules between cells. In the aging field, these EVs have been shown to regulate important aging processes, such as oxidative stress or senescence, both in vivo and in vitro. EVs from healthy cells, particularly those coming from stem cells (SCs), have been described as potential effectors of the regenerative potential of SCs. Many studies with different animal models have shown promising results in the field of regenerative medicine. EVs are now viewed as a potential cell-free therapy for tissue damage and several diseases. Here we propose EVs as regulators of the aging process, with an important role in tissue regeneration and a raising therapy for age-related diseases.
衰老是与细胞间通讯的改变相关联的。细胞外环境的这些变化有助于衰老表型的形成,并与不同的与衰老相关的疾病有关。细胞外囊泡(EVs)是介导细胞间信号分子传递的因素。在衰老领域,这些 EVs 已被证明可以调节重要的衰老过程,如体内和体外的氧化应激或衰老。来自健康细胞的 EVs,特别是来自干细胞(SCs)的 EVs,已被描述为SCs 再生潜力的潜在效应物。许多使用不同动物模型的研究在再生医学领域显示出了有前景的结果。EVs 现在被视为组织损伤和几种疾病的潜在无细胞治疗方法。在这里,我们提出 EVs 是衰老过程的调节剂,在组织再生和提高与年龄相关的疾病的治疗方面具有重要作用。